awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33588346-E6EF0C0F-174E-410C-B2CA-1A62EDECADA0
Q33588346-E6EF0C0F-174E-410C-B2CA-1A62EDECADA0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33588346-E6EF0C0F-174E-410C-B2CA-1A62EDECADA0
Health economics perspective of fesoterodine, tolterodine or solifenacin as first-time therapy for overactive bladder syndrome in the primary care setting in Spain
P2860
Q33588346-E6EF0C0F-174E-410C-B2CA-1A62EDECADA0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33588346-E6EF0C0F-174E-410C-B2CA-1A62EDECADA0
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
5eb72ba7d0d6fa1c44c64be34ef7bd9c6354b140
P2860
Efficacy, safety and tolerability of fesoterodine for overactive bladder syndrome.